Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A concise guide on selecting core crypto assets for beginners who plan to buy and hold for the long term.
28,656 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
GLAD faces a delicate turning point as the Fed freezes rates, pressuring yields on its floating-rate loans while port...
Inflation cools and growth slows, reviving worries about stagflation. Analysts say america being haunted 1970s could ...
PEY sits at a crossroads, pairing long-running dividend growers with higher-yielding, potentially riskier payors. As ...
Two popular cash parking ETFs—JPST and SCHO—continue to guide traders between trades and rate cycles. Over five years...
Traders on the solana-based meme coin launchpad Pump.fun reverse losses in 2026 as profitability climbs, per CoinGeck...
U.S.-listed XRP ETFs attracted $25.8 million in a single day, the strongest inflow since January, pushing total ETF i...
Bitcoin hovers near $80K as Glassnode flags $469 billion in exposure to quantum risk, fueling the bitcoin price predi...
Bitcoin tumbles past a key ascending pattern, pushing toward $60,000 as investors reassess risk. Traders ask where co...
Ethereum eyes the $2,000 mark as EthSystems launches to bring confidential, enterprise-grade privacy features to inst...
Crescent Capital BDC offers a high-yield opportunity along with risks linked to debt investments. This guide breaks d...
Juggling a full-time job and a bustling household, one parent stacked eight real estate deals in just two years. This...